Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Omnitrope Pen 10 10mg/1.5ml inj cartridges
0605010S0BHACBL
|
Omnitrope | Somatropin | Endocrine System | No data available |
|
On Call Now testing strips
0601060D0BZAAA0
|
On Call Now (Reagent) | Glucose blood testing reagents | Endocrine System | No data available |
|
On Call Plus testing strips
0601060D0CDAAA0
|
On-Call Plus (Reagent) | Glucose blood testing reagents | Endocrine System | No data available |
|
OneTouch testing strips
0601060D0BHAAA0
|
OneTouch (Reagent) | Glucose blood testing reagents | Endocrine System | No data available |
|
OneTouch Ultra testing strips
0601060D0BHABA0
|
OneTouch (Reagent) | Glucose blood testing reagents | Endocrine System | No data available |
|
OneTouch Vita testing strips
0601060D0BHACA0
|
OneTouch (Reagent) | Glucose blood testing reagents | Endocrine System | No data available |
|
Orgalutran 250microgram/0.5ml inj pre-filled syringe
0607020W0BBAAAA
|
Orgalutran | Ganirelix | Endocrine System | No data available |
|
Ostiral 60mg tablets
0604011X0BEAAAA
|
Ostiral | Raloxifene hydrochloride | Endocrine System | No data available |
|
Ovaleap 300units/0.5ml solution for injection cartridges
0605010I0BDAAAR
|
Ovaleap | Follitropin alfa | Endocrine System | No data available |
|
Ovaleap 450units/0.75ml solution for injection cartridges
0605010I0BDABAS
|
Ovaleap | Follitropin alfa | Endocrine System | No data available |
|
Ovaleap 900units/1.5ml solution for injection cartridges
0605010I0BDACAT
|
Ovaleap | Follitropin alfa | Endocrine System | No data available |
|
Ovestin 1mg tablets
0604011M0BBABAB
|
Ovestin (Systemic) | Estriol | Endocrine System | No data available |
|
Ovitrelle 250microgram inj vials
0605010X0BBAAAA
|
Ovitrelle | Choriogonadotropin alfa | Endocrine System | No data available |
|
Oxandrin 2.5mg tablets
0604030P0BCAAAB
|
Oxandrin | Oxandrolone | Endocrine System | No data available |
|
Pamidronate disodium 15mg pdr & solv for soln inf vials
0606020P0AAABAB
|
Pamidronate disodium | Pamidronate disodium | Endocrine System | No data available |
|
Pamidronate disodium 15mg pdr for soln inf vials
0606020P0AAAMAM
|
Pamidronate disodium | Pamidronate disodium | Endocrine System | No data available |
|
Pamidronate disodium 15mg/1ml solution for infusion ampoules
0606020P0AAAQAQ
|
Pamidronate disodium | Pamidronate disodium | Endocrine System | No data available |
|
Pamidronate disodium 15mg/5ml solution for infusion vials
0606020P0AAAIAI
|
Pamidronate disodium | Pamidronate disodium | Endocrine System | No data available |
|
Pamidronate disodium 30mg inf vials
0606020P0AAACAC
|
Pamidronate disodium | Pamidronate disodium | Endocrine System | No data available |
|
Pamidronate disodium 30mg inj vials
0606020P0AAANAN
|
Pamidronate disodium | Pamidronate disodium | Endocrine System | No data available |
|
Pamidronate disodium 30mg/10ml solution for infusion vials
0606020P0AAAJAJ
|
Pamidronate disodium | Pamidronate disodium | Endocrine System | No data available |
|
Pamidronate disodium 30mg/2ml solution for infusion ampoules
0606020P0AAARAR
|
Pamidronate disodium | Pamidronate disodium | Endocrine System | No data available |
|
Pamidronate disodium 60mg/10ml solution for infusion vials
0606020P0AAAGAG
|
Pamidronate disodium | Pamidronate disodium | Endocrine System | No data available |
|
Pamidronate disodium 60mg/20ml solution for infusion vials
0606020P0AAAKAK
|
Pamidronate disodium | Pamidronate disodium | Endocrine System | No data available |
|
Pamidronate disodium 60mg/4ml solution for infusion ampoules
0606020P0AAASAS
|
Pamidronate disodium | Pamidronate disodium | Endocrine System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.